Delivery Order SPE2DX22D0020-SPE2D826F00CF
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $91,278.31 firm fixed price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract will be performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,532.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,330.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with a completion date of October 7, 2025. This firm fixed-price, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 master vehicle running through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $211,138.11 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,484.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 7, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,775.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,946.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,745.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,779.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on June 21, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $24,909.96 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work is to be performed at...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F00CFDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $791,968.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. Under this delivery order, AmerisourceBergen is supplying pharmaceutical products and medical supplies to support federal medical procurement needs for military and veteran healthcare systems. The company's contract portfolio with the DLA Medical Supply Chain encompasses a comprehensive range of medical commodities, including brand-name and generic medications, vaccines, specialized pharmaceuticals for conditions such as diabetes and neurological disorders, pain management drugs, antibiotics, and related medical supplies. This delivery order exemplifies the company's role as a critical vendor within the DLA's pharmaceutical support infrastructure, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $792.0k | 10/1/25 |